Quiz 4 – NovoNordisk Quiz Game

Welcome To Novonordisk Quiz Game

1 / 5

From which age is Saxenda® approved for the treatment of obesity?

12 years old

18 years old

10 years old

2 / 5

What is the % of women with severe (Class III) obesity who experience urinary incontinence?

40% to 50%

60% to 70%

20% to 30%

3 / 5

What is the % of adolescents with obesity who will continue to have obesity in adulthood if left untreated?

80%

100%

30%

4 / 5

Up to _________ of women with PCOS have obesity.

36%

56%

76%

5 / 5

What are some benefits beyond weight loss with Saxenda®?

Cardiovascular benefits

Lowered blood glucose levels and risk of diabetes

Improved blood pressure

All the above

Your score is

The average score is 100%